M&A: urge to merge proves irresistible

Analysts note that deal-making often accelerates close to the top of a cycle. So it could bode ill that January marked the strongest start to a year for global mergers and acquisitions (M&A) since the peak of the dotcom boom in 2000, especially in light of the nasty market wobble over the past few days. In total, $367bn worth of deals were agreed, notably French drugmaker Sanofi's $11.4bn purchase of biotech company Bioverativ.

There were 11 transactions worth more than $5bn. In the UK, the value of M&A jumped to £421bn, up 33% on the previous year. Meanwhile, 2017 was the fourth year in a row that worldwide M&A exceeded $3trn an unprecedented streak.

M&A always flourishes when animal spirits are high. Until last week, the S&P 500 spent 202 consecutive days within 3% of an all-time high, s Michael Batnick on Ritholtz.com a new record. Market confidence in the economic backdrop has risen. And US tax reform appears to have given the urge to merge added impetus, with many of the deals announced coming from across the Atlantic.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Companies can expect a corporation tax cut from 35% to 21%, and will be allowed to bring overseas earnings back, increasing the war chest for acquisitions. Still, given the nervous start to February, January's figure may not be eclipsed for some time.